WNT Pathway clinical trials at UCSF
1 research study open to eligible people
The WNT pathway is a set of signals cells use to control growth and development. UCSF is studying a WNT-targeting medicine in people with locally advanced or metastatic solid tumors. The study gathers information about safety and how well the medicine works.
Showing trials for
FOG-001 in Locally Advanced or Metastatic Solid Tumors
open to eligible people ages 18 years and up
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic cancer.
San Francisco, California and other locations
Last updated: